CLL-115 First Interim Analysis of ALPINE Study: Results of a Phase 3 Randomized Study of Zanubrutinib vs Ibrutinib in Patients With Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL)

Jennifer R. Brown, Wojciech Jurczak, Nicole Lamanna et al.|Clinical Lymphoma Myeloma & Leukemia|2022

Cited by 12